Text Size
253 studies found for:    shingles

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Unknown † Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Interventions: Drug: ARYS-01 (sorivudine) cream 3% or placebo cream;   Drug: placebo;   Drug: valaciclovir
22 Active, not recruiting Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged >= 50 Years
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine GSK1437173A;   Biological: Placebo
23 Completed Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital
Condition: Herpes Zoster
Intervention: Behavioral: Education
24 Completed A Study to Test the Safety and Antibody Response of V212 in Healthy Adults
Conditions: Herpes Zoster;   Shingles
Interventions: Biological: Comparator: V212;   Biological: Comparator: Placebo
25 Completed Immune Response to Varicella-Zoster Vaccination and Infection
Conditions: Chickenpox;   Herpes Zoster
Intervention:
26 Completed
Has Results 		Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Conditions: Herpes Zoster;   HIV Infections
Interventions: Biological: ZOSTAVAX;   Biological: Placebo
27 Recruiting Cytokine Production and Immunity to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine
Condition: Immunity; Defect Due to Antibody or Cell Mediated Immune Defect
Intervention:
28 Completed Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK 1437173A
29 Completed
Has Results 		Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)
Condition: Shingles
Interventions: Biological: Zoster Vaccine, Live (Zostavax™);   Biological: Comparator: Placebo
30 Completed Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)
Conditions: Herpes Zoster;   Shingles
Interventions: Biological: Zoster Vaccine Live (AMP);   Biological: Zoster Vaccine Live
31 Active, not recruiting Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects
Condition: Herpes Zoster Vaccine
Intervention: Procedure: Blood sample
32 Completed
Has Results 		A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Comparator: Zostavax™;   Biological: Comparator: Placebo;   Other: VZV Skin Test;   Other: Saline
33 Terminated Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Intervention: Drug: Pregabalin
34 Recruiting Acupuncture in Herpes Zoster Neuralgia (ACUZoster)
Conditions: Herpes Zoster;   Postherpetic Neuralgia;   Pain
Interventions: Device: Sham-laser acupuncture;   Drug: gabapentine;   Procedure: Acupuncture
35 Recruiting A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Placebo
36 Completed Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: Zoster Vaccine Live
37 Completed Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in Korea (V211-034 AM2)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: Zoster Vaccine Live
38 Completed Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
Conditions: Chickenpox;   Herpes Zoster
Intervention: Drug: famciclovir
39 Active, not recruiting Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Condition: Herpes Zoster Vaccine
Interventions: Biological: Herpes Zoster Vaccine 1437173A;   Biological: Placebo
40 Recruiting Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Condition: Herpes Zoster (HZ)
Interventions: Biological: Herpes Zoster vaccine GSK1437173A;   Biological: Placebo
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years